| Nova Lee Szoka, MD | |
|
1 Medical Center Dr, Morgantown, WV 26506-1200 | |
| (800) 782-6945 | |
| Not Available |
| Full Name | Nova Lee Szoka |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 14 Years |
| Location | 1 Medical Center Dr, Morgantown, West Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912227083 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| West Virginia University Hospitals | Morgantown, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| West Virginia University Medical Corporation | 1052224565 | 1613 |
News Archive
Many risk factors for breast cancer are well studied and documented. Thus, scientists are sure by now that early first menstrual period, late onset of menopause and a family history of breast cancer are associated with an increased breast cancer risk.
The Optical Research Group of the Universitat Jaume I has developed an optical nanoparticle sensor capable of detecting very low glucose concentrations, such as those present in a person's tear, by means of fluorescent carbon quantum dots, applying synthesis of nanomaterials based on irradiation with ultra-short lasers, which is an alternative, sustainable and non-polluting method.
Albumedix Ltd. (‘Albumedix'), an enabler of advanced therapies and the world leader in recombinant human albumin (rAlb), announced today that they have entered into a collaboration agreement with Cell and Gene Therapy Catapult (CGT Catapult) to investigate the use of Albumedix´ proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.
"Nearly 30 years into the AIDS epidemic, we are able to access our progress in tackling the disease with both increased knowledge and the benefit of hindsight," former UNAIDS Executive Director Peter Piot of Imperial College London, who also serves as an adviser on global health strategy to the Bill & Melinda Gates Foundation; Michel Kazatchkine, executive director of the Global Fund To Fight AIDS, Tuberculosis and Malaria; Mark Dybul of the O'Neill Institute for National and Global Health Law at Georgetown University and former U.S. Global AIDS Coordinator; and Julian Lob-Levyt of the GAVI Alliance write in a Lancet opinion piece.
› Verified 7 days ago
| Entity Name | West Virginia University Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275504508 PECOS PAC ID: 1052224565 Enrollment ID: O20031111000207 |
News Archive
Many risk factors for breast cancer are well studied and documented. Thus, scientists are sure by now that early first menstrual period, late onset of menopause and a family history of breast cancer are associated with an increased breast cancer risk.
The Optical Research Group of the Universitat Jaume I has developed an optical nanoparticle sensor capable of detecting very low glucose concentrations, such as those present in a person's tear, by means of fluorescent carbon quantum dots, applying synthesis of nanomaterials based on irradiation with ultra-short lasers, which is an alternative, sustainable and non-polluting method.
Albumedix Ltd. (‘Albumedix'), an enabler of advanced therapies and the world leader in recombinant human albumin (rAlb), announced today that they have entered into a collaboration agreement with Cell and Gene Therapy Catapult (CGT Catapult) to investigate the use of Albumedix´ proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.
"Nearly 30 years into the AIDS epidemic, we are able to access our progress in tackling the disease with both increased knowledge and the benefit of hindsight," former UNAIDS Executive Director Peter Piot of Imperial College London, who also serves as an adviser on global health strategy to the Bill & Melinda Gates Foundation; Michel Kazatchkine, executive director of the Global Fund To Fight AIDS, Tuberculosis and Malaria; Mark Dybul of the O'Neill Institute for National and Global Health Law at Georgetown University and former U.S. Global AIDS Coordinator; and Julian Lob-Levyt of the GAVI Alliance write in a Lancet opinion piece.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nova Lee Szoka, MD 1 Medical Center Dr, Morgantown, WV 26506-1200 Ph: (800) 782-6945 | Nova Lee Szoka, MD 1 Medical Center Dr, Morgantown, WV 26506-1200 Ph: (800) 782-6945 |
News Archive
Many risk factors for breast cancer are well studied and documented. Thus, scientists are sure by now that early first menstrual period, late onset of menopause and a family history of breast cancer are associated with an increased breast cancer risk.
The Optical Research Group of the Universitat Jaume I has developed an optical nanoparticle sensor capable of detecting very low glucose concentrations, such as those present in a person's tear, by means of fluorescent carbon quantum dots, applying synthesis of nanomaterials based on irradiation with ultra-short lasers, which is an alternative, sustainable and non-polluting method.
Albumedix Ltd. (‘Albumedix'), an enabler of advanced therapies and the world leader in recombinant human albumin (rAlb), announced today that they have entered into a collaboration agreement with Cell and Gene Therapy Catapult (CGT Catapult) to investigate the use of Albumedix´ proprietary albumin-based solutions for advanced therapy applications, including viral vectors manufacturing.
"Nearly 30 years into the AIDS epidemic, we are able to access our progress in tackling the disease with both increased knowledge and the benefit of hindsight," former UNAIDS Executive Director Peter Piot of Imperial College London, who also serves as an adviser on global health strategy to the Bill & Melinda Gates Foundation; Michel Kazatchkine, executive director of the Global Fund To Fight AIDS, Tuberculosis and Malaria; Mark Dybul of the O'Neill Institute for National and Global Health Law at Georgetown University and former U.S. Global AIDS Coordinator; and Julian Lob-Levyt of the GAVI Alliance write in a Lancet opinion piece.
› Verified 7 days ago
Rohma Shamsi, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 1 Medical Center Drive, Morgantown, WV 26506 Phone: 304-293-4125 | |
Islam Younes, Internal Medicine Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 855-988-2273 | |
Dr. David Weissman, M. D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Stadium Drive, Morgantown, WV 26506 Phone: 304-598-4800 Fax: 304-293-6963 | |
Dr. Madhavi Kadiyala, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 304-598-4000 | |
Dr. Swapna Gayam, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Drive, Morgantown, WV 26506 Phone: 304-293-4123 Fax: 304-293-2135 | |
Monika Maximilliane Holbein, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 304-594-4000 | |
Nour Daboul, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 855-988-2273 |